Advances in Retinopathy of Prematurity / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 261-266, 2019.
Article
in Zh
| WPRIM
| ID: wpr-776040
Responsible library:
WPRO
ABSTRACT
Retinopathy of prematurity(ROP)is a pathological neovascularization with fibrotic changes in the fundus of premature infants.It is a major cause of preventable blindness in children in both developing and developed countries.Treatment of ROP has long been a hot research topic in ophthalmology and pediatrics.With a clearer knowledge of the pathogenesis of ROP,more basic and clinical studies have been carried out.The anti-vascular endothelial growth factor therapy and surgical treatment have become mature strategies,and a variety of therapeutic drugs including insulin-like growth factor-1,transforming growth factor-β,polyunsaturated fatty acids,and β-adrenergic receptor blockers have been developed.This article reviews the recent advances in ROP.
Full text:
1
Index:
WPRIM
Main subject:
General Surgery
/
Therapeutics
/
Retinopathy of Prematurity
/
Infant, Premature
/
Vascular Endothelial Growth Factor A
/
Drug Therapy
/
Neovascularization, Pathologic
Limits:
Child
/
Humans
/
Newborn
Language:
Zh
Journal:
Acta Academiae Medicinae Sinicae
Year:
2019
Type:
Article